As existing resources are continually stretched thinner and thinner, experts and dialysis providers say it is crucial for ...
Targeting and disabling a certain protein essential to transporting glucose properly through cells (Glucose Transporter 1, or Glut1) could be a new way to fight kidney disease, according to a study ...
A rare and life-threatening kidney disease in children finally has an effective therapy, thanks in large part to pioneering ...
Kidney disease is one of the leading causes of deaths globally. A global analysis published in The Lancet found that chronic kidney disease (CKD) is the ninth leading cause of death worldwide. The ...
Chronic kidney disease (CKD) can cause dysfunction in organs well outside the renal system. The skin is one of the organs most commonly affected. CKD is a “chronic inflammatory state, which means it ...
Experts convened in Cleveland, Ohio, on November 11, 2025, to discuss the evolution of cardio-renal-metabolic care from ...
Credit: Getty Images. Empagliflozin is a sodium-glucose co-transporter 2 inhibitor. The Food and Drug Administration (FDA) has approved Jardiance ® (empagliflozin) to reduce the risk of sustained ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback